TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
BUY
They have a clear growth opportunity outside of Canada.
TOP PICK
Likes their acquisition of John Hancock. It improves their footprint and product line in the US. Strong management team. Buy on any weakness.
BUY
Well-run. The John Hancock acquisition makes a lot of sense.
BUY
Has a long term future. Insurance companies will grow in a 10/15% range, dividends included.
TOP PICK
The John Hancock merger is very good for shareholders. Gives Manulife a footprint into the US. Strong management team. Could be some volatility which will be a buying opportunity.
BUY
Acquisition of John Hancock was a good move. A risk will be if John Hancock shareholders decide to sell their shares, but Manulife has a pretty strong buyback position on this. An interesting stock. Well-positioned for the long term.
DON'T BUY
From a fair market value point of view, it has nothing for you. Not terribly bullish in the short term. What they are doing makes good sense and the growth outlook is reasonable.
TOP PICK
(A top pick Oct 6/03. Up 3½%.) Good synergies with the takeover of John Hancock. Cheap at 11 X earnings.
BUY
Likes life insurance companies and this stock had taken a drop to a good price.
WAIT
The deal with John Hancock doesn't close until next April so would wait closer to that date before buying. Some of the US funds may decide to drop John Hancock shares.
TOP PICK
Has dropped with the takeover of John Hancock. As a value investment, three to five years from now it has the prospects to build back up.
TOP PICK
Likes their acquisition of John Hancock. Have done a good job of integrating in the past.
TOP PICK
John Hancock is a good strategic acquisition/merger. Valuation is very attractive. Stock will remain under pressure for a while.
BUY
The John Hancock acquisition is a good platform for the US. Will take two years to consolidate so may not move very much. Should be a great core holding.
DON'T BUY
Likes the company but would like it at a lower price.
Showing 2,056 to 2,070 of 2,281 entries